Doubling time of serum CA125 is an independent prognostic factor for survival in patients with ovarian cancer relapsing after first-line chemotherapy

✍ Scribed by Liz Y. Han; Vasilios Karavasilis; Tom van Hagen; Shibani Nicum; Karen Thomas; Michelle Harrison; Panagiotis Papadopoulos; Peter Blake; Desmond P.J. Barton; Martin Gore; Stan B. Kaye

• Book ID: 116430311
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 156 KB
• Volume: 46
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2010.02.012